MJP Associates Inc. ADV Decreases Stock Position in The Procter & Gamble Company (NYSE:PG)

MJP Associates Inc. ADV lowered its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 8.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,985 shares of the company’s stock after selling 555 shares during the quarter. MJP Associates Inc. ADV’s holdings in Procter & Gamble were worth $877,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Axiom Financial Strategies LLC boosted its stake in shares of Procter & Gamble by 7.0% during the first quarter. Axiom Financial Strategies LLC now owns 1,728 shares of the company’s stock valued at $276,000 after purchasing an additional 113 shares during the period. AMI Investment Management Inc. increased its position in shares of Procter & Gamble by 7.2% in the 1st quarter. AMI Investment Management Inc. now owns 3,461 shares of the company’s stock valued at $529,000 after purchasing an additional 233 shares during the last quarter. LSV Asset Management raised its stake in shares of Procter & Gamble by 5.7% during the first quarter. LSV Asset Management now owns 18,600 shares of the company’s stock worth $2,842,000 after purchasing an additional 1,000 shares during the last quarter. Ergoteles LLC acquired a new stake in Procter & Gamble during the 1st quarter valued at $3,073,000. Finally, Wsfs Capital Management LLC boosted its holdings in shares of Procter & Gamble by 12.0% in the 1st quarter. Wsfs Capital Management LLC now owns 4,256 shares of the company’s stock valued at $650,000 after purchasing an additional 455 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 0.2 %

NYSE:PG traded down $0.36 during trading hours on Thursday, reaching $162.25. 6,768,850 shares of the stock were exchanged, compared to its average volume of 6,853,413. The stock has a market cap of $381.78 billion, a PE ratio of 27.19, a PEG ratio of 3.28 and a beta of 0.44. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $163.14. The firm has a 50 day moving average of $158.42 and a 200 day moving average of $152.16. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.64 and a quick ratio of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.14. The firm had revenue of $21.44 billion for the quarter, compared to the consensus estimate of $21.48 billion. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The company’s revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.59 EPS. On average, equities analysts expect that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were given a dividend of $0.9407 per share. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date was Thursday, January 18th. Procter & Gamble’s payout ratio is currently 62.98%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The disclosure for this sale can be found here. Over the last three months, insiders sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on PG shares. UBS Group raised their price target on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. JPMorgan Chase & Co. reduced their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a research report on Thursday, January 18th. Wells Fargo & Company boosted their price target on shares of Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a report on Wednesday, January 24th. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and raised their price objective for the company from $160.00 to $175.00 in a report on Monday, March 11th. Finally, Raymond James upped their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $168.41.

Check Out Our Latest Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.